Skip to main content
Figure 4 | Critical Care

Figure 4

From: Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time

Figure 4

GlucoStabilizer management of all patients, compared with those with AMI, CABG, diabetes, and renal failure. (a) Time to achieve target range, hours, median and interquartile range; (b) Mean blood glucose after target range achieved, mean and standard deviation; (c) Number of hypoglycemic episodes per 1000 hours; (d) Percent of time in ranges 4.4 to 6.1, 3.9 to 6.7, 3.9 to 7.2, and 3.9 to 8.3 mmol/L after target range achieved. All = all patients (5456 drip runs); Sepsis = (658 drip runs); AMI = acute myocardial infarction (160 drip runs); CABG = coronary artery bypass graft (444 drip runs); DM+ = with diabetes (2717 drip runs); DM- = without diabetes (2647 drip runs); Type 1 DM = type 1 diabetes (126 drip runs); Renal = new onset acute renal failure, chronic kidney disease, or on dialysis (2207 drip runs). The value in mmol/L can be calculated by multiplying the mg/dL value by 0.05551.

Back to article page